Concepedia

Katsuya Higo

KH

8

Publications

364

Citations

8

H-Index

1992

Active since

Affiliations

Kyowa Kirin (Japan)(Current)

University of California San Diego

Katsuya Higo is an author at Kyowa Kirin (Japan) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1992–2004

8

Publications

8

TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone

Philip D.G. Miles, Oreste Romeo, Katsuya Higo et al. · Diabetes · 1997 · 183 citations

Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.

Philip D.G. Miles, Katsuya Higo, Oreste Romeo et al. · Diabetes · 1998 · 45 citations

Blockade by calmodulin inhibitors of Ca<sup>2+</sup> channels in smooth muscle from rat vas deferens

Ken Nakazawa, Katsuya Higo, Kazuho Abe et al. · British Journal of Pharmacology · 1993 · 41 citations · Full text

, , +19

K579, a slow-binding inhibitor of dipeptidyl peptidase IV, is a long-acting hypoglycemic agent

Kotaro Takasaki, Miho Iwase, Takao Nakajima et al. · European Journal of Pharmacology · 2004 · 32 citations

, , +10

Effects of Combination Treatment With Dipeptidyl Peptidase IV Inhibitor and Sulfonylurea on Glucose Levels in Rats

Kotaro Takasaki, Takao Nakajima, Kimihisa Ueno et al. · Journal of Pharmacological Sciences · 2004 · 25 citations · Full text

Rows per page

1–5 of 8